Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00451412 | A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients | PHASE3 | COMPLETED | 3,254 | — | — | Jan 1, 2007 | Jun 1, 2009 | Jul 25, 2012 | 1 | Germany |
| Arm | Type | Description |
|---|---|---|
| Certoparin | EXPERIMENTAL | - |
| Unfractionated Heparin | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Certoparin | DRUG | 3000 U anti XA of certoparin in 0.3 ml solution, once daily |
| Unfractionated Heparin | DRUG | solution, 5000 IU of unfractionated heparin in 0.3 ml, 3 times daily |
Inclusion Criteria: 1. Hospitalized medical patients 70 years of age or older 2. Acute medical illness with significant decrease in mobility expected for at least 4 days (patient bedridden or only able to walk short distances) 3. written informed consent Exclusion Criteria: 1. immobilization long...